Zinger Key Points
- Bath & Body Works posts Q1 revenue of $1.38 billion, beating the analyst consensus estimate of $1.36 billion.
- Bath & Body Works narrows FY24 sales outlook to decline of 2.5% - 0%.
- Get Monthly Picks of Market's Fastest Movers
Bath & Body Works Inc BBWI reported a first-quarter FY24 sales decline of 0.9% year-on-year to $1.38 billion, beating the analyst consensus estimate of $1.36 billion.
The change in year-over-year net sales benefited by approximately 200 basis points from the shifted fiscal calendar, as expected, offset by an impact of approximately 170 basis points resulting from weaker-than-expected results from certain international markets.
Gross profit increased 1.7% Y/Y to $606 million with a margin of 43.8%. The operating margin was 13.5%, and operating income for the quarter rose 3.3% to $187 million.
Adjusted EPS of $0.38 beat the analyst consensus estimate of $0.32.
Bath & Body Works held $855 million in cash and equivalents as of May 4, 2024. At the end of the first quarter, inventories increased 5.6% Y/Y to $814 million.
The operating cash flow for the quarter was $76 million. Bath & Body Works’ regular quarterly dividend of $0.20 per share is payable on June 21 to shareholders of record on June 7.
Outlook: Bath & Body Works narrowed FY24 EPS guidance to $3.05-$3.35 (prior $3.00 – $3.35) versus the consensus of $3.31.
The company also narrowed its FY24 sales outlook to decline of 2.5% – 0% (prior decline of 3% – 0%).
The company sees second-quarter sales to decline 2% – flat and sees EPS of $0.31 – $0.36, versus the consensus estimate of $0.39.
Price Action: BBWI shares are trading lower by 5.56% at $48.93 at the last check Tuesday.
Photo via Wikimedia Commons
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.